The present study examined for the first time the role of gene polymorphisms of IDO (IDO1 and IDO2) and its inducer and serum IDO1 levels in the risk of PSD at 2 weeks after stroke onset and also discussed the relationship between cytokine SNPs and serum IDO1 levels. This evidence concerns the gene IDO1 and Stroke.